Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Aierhaitai Pharmaceutical is a Chinese pharmaceutical company based in Shijiazhuang, specializing in the research, development, and production of biochemical drugs. As a key subsidiary of Hebei Changshan Biochemical Pharmaceutical, the company focuses heavily on heparin-based anticoagulants, including heparin sodium and low molecular weight heparins like enoxaparin and dalteparin. Aierhaitai operates large-scale GMP-certified manufacturing facilities and supports the parent company's expansion into metabolic diseases, particularly through the production of peptide-based therapeutics. Their portfolio serves both domestic and international markets, emphasizing high-quality API and finished dosage form production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Aierhaitai Pharmaceutical.